Hyaluronan synthase (HAS) inhibitor and the anti-carcinogenic drug, 4-MU reverts these changes with decreased tumor potency and elevated expression of tumor suppressor protein, PTEN, Beclin1 and increased autophagic vacuole formation [113]. The gene discussed is PTEN; the disease is neoplasm.